| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.80▼ | 4.85▼ | 4.87▼ | 5.04▼ | 4.43▲ |
| MA10 | 4.81▼ | 4.85▼ | 4.83▼ | 4.70▲ | 4.28▲ |
| MA20 | 4.84▼ | 4.83▼ | 4.94▼ | 4.47▲ | 4.51▲ |
| MA50 | 4.83▼ | 5.04▼ | 4.90▼ | 4.26▲ | 6.13▼ |
| MA100 | 4.83▼ | 4.82▼ | 4.52▲ | 4.66▲ | 8.98▼ |
| MA200 | 5.02▼ | 4.48▲ | 4.44▲ | 5.82▼ | 9.80▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | 0.009▲ | -0.022▼ | 0.064▲ | 0.168▲ |
| RSI | 35.768▼ | 43.084▼ | 44.151▼ | 55.567▲ | 46.883▼ |
| STOCH | 10.069▼ | 64.242 | 50.121 | 67.141 | 54.718 |
| WILL %R | -100.000▼ | -58.182 | -79.646▼ | -51.842 | -43.392 |
| CCI | -118.954▼ | -39.080 | -53.075 | 38.853 | 127.545▲ |
|
Wednesday, September 04, 2019 02:19 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney ...
|
|
Tuesday, September 03, 2019 05:00 AM
Akebia Therapeutics, Inc. (Nasdaq: AKBA) today announced full enrollment of its global Phase 3 program evaluating the safety and efficacy of vadadustat for the treatment of anemia due to chronic ...
|
|
Monday, July 15, 2019 11:11 PM
The stock is even more appealing given the large drop in share price. Source: Seeking Alpha There has been significant price movement in the stock of Akebia Therapeutics (NASDAQ:AKBA) since our last ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/09/19 | 4.895 | 4.945 | 4.67 | 4.785 | 469,542 |
| 16/09/19 | 5.08 | 5.19 | 4.68 | 4.78 | 1,005,500 |
| 13/09/19 | 5.28 | 5.29 | 4.83 | 5.10 | 1,166,300 |
| 12/09/19 | 5.26 | 5.46 | 5.09 | 5.26 | 1,065,000 |
| 11/09/19 | 5.43 | 5.77 | 4.90 | 5.27 | 1,558,620 |
| 10/09/19 | 4.27 | 5.42 | 4.24 | 5.40 | 1,830,651 |
| 09/09/19 | 4.10 | 4.32 | 4.01 | 4.28 | 575,500 |
| 06/09/19 | 4.09 | 4.20 | 3.99 | 4.07 | 575,700 |
| 05/09/19 | 4.00 | 4.13 | 4.00 | 4.09 | 663,826 |
| 04/09/19 | 4.13 | 4.19 | 3.87 | 3.92 | 841,800 |
|
|
||||
|
|
||||
|
|